$16.48
▲ +1.6% Today
as of Oct 23, 15:35 ET
Last 30 days
RLYB earnings at a glance
Rallybio Corporation (RLYB) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Over its last 4 reports the stock rose the next day 2 times and fell 2, moving ±2.6% on average; after the most recent report on May 13, 2026 it moved +2.3%. RLYB beat the consensus EPS estimate in 1 of its last 2 reported quarters. The share price of $16.48 sits near its 52-week high.
Overview
52-week range
$3.67
$18
92% of range
Avg surprise (last 2)
+22.0%
Avg reaction (last 4)
-0.3%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-1.46 | — | — | -595.2% | +2.3% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-0.14 | $-0.25 | +44.0% | — | +2.2% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | $-0.22 | — | — | — | -3.2% | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.21 | $-0.21 | 0.0% | — | -2.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.26 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.37 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.47 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.45 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.46 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.43 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-0.60 | — | — | — | — | financials |
| Thu Jun 30, 2022 | Jun 2022 | $-0.57 | — | — | — | — | financials |
| Thu Mar 31, 2022 | Mar 2022 | $-0.48 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | — | -$1.12 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $212,000 | — | $212,000 | — | — | — | $299,000 | $299,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-9M | — | $-7M | — | — | — | $-12M | $-17M |
| Net income | $-8M | — | $16M | — | — | — | $-11M | $-16M |
| EPS (diluted) | $-1.46 | — | $0.36 | $-0.22 | — | — | $-0.26 | $-0.37 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $41M | $31M | $32M | $9M | $15M | $14M | $25M | $17M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $53M | $61M | $67M | $50M | $57M | $68M | $78M | $91M |
| Total assets | $54M | $62M | $68M | $51M | $58M | $68M | $79M | $92M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $4M | $5M | $5M | $4M | $6M | $8M | $12M |
| Total equity | $50M | $58M | $63M | — | — | $62M | $71M | $80M |
Implied volatility — last 90 days
No IV snapshots yet for RLYB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
RLYB earnings FAQ
When is RLYB's next earnings date?
Rallybio Corporation is expected to report on November 5, 2026.
How does RLYB stock usually react to earnings?
Across the last 4 reports the average next-day move was ±2.6%, up 2 times and down 2 times.